Published on:2nd Sept, 2014
    Journal of Cardiovascular Disease Research, 2014; 5(3):9-12
    Review Article | doi:10.5530/jcdr.2014.3.3

    Revascularization in chronic stable angina-does it really benefit as first line therapy.


    Alok Kumar Singh*

    Department of Cardiology, Interventional Cardiologist, Heritage Hospital, Varanasi, India.


    Coronary artery disease (CAD) remains a major global public health problem in 21st century, and it affects as many as 54 million people globally.1 The goals of CAD treatment have several objectives which include relief of symptoms, inhibition of disease progression, prevention of future cardiac events, such as myocardial infarction (MI) and improved survival.2 There is always debate among medical treatment and revascularization which one is superior to each other. Here, we will discuss and try to review in a critical manner the role of revascularization (percutaneous coronary intervention [PCI] versus coronary artery bypass grafting [CABG]) in the management of chronic stable angina in comparison to modern optimal medical therapy (OMT) in the view of recent studies.

    Key words: Angina, optimal medical therapy, revascularization.

    Article Download